help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Widmaier, E. P.
Right arrow Articles by Abbott, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Widmaier, E. P.
Right arrow Articles by Abbott, B.

Endocrinology, Vol 131, 2313-2318, Copyright © 1992 by Endocrine Society


ARTICLES

Free fatty acids activate the hypothalamic-pituitary-adrenocortical axis in rats

EP Widmaier, K Rosen and B Abbott
Department of Biology, Boston University, Massachusetts 02215.

Intravenous administration of Intralipid 10% increases blood levels of essential free fatty acids. In rats and man, this is associated with an inhibition of GH secretion from the anterior pituitary. Because GH is lipolytic, the inhibition of its secretion may represent a negative feedback action of the fats on pituitary sensitivity to GH-releasing hormone. Since corticosterone, the final secretory product of the rat hypothalamic-pituitary-adrenocortical (HPA) axis, is also lipolytic, we tested the hypothesis that FFA would inhibit the HPA axis. Rats were cannulated via the jugular vein and infused with different doses of heparin-Intralipid 10% or heparin-saline; sequential blood samples were obtained and analyzed for ACTH, corticosterone, FFA, and glucose. Intralipid at 2.85 ml/kg increased plasma FFA to over 3 meq/liter by 15 min, with a return to baseline by 60-90 min. There was no effect of the infusion on plasma osmolarity or pH. At 60 min, plasma ACTH levels were significantly elevated to over 1500 pg/ml in Intralipid-infused rats, but were unchanged in saline controls. This dose of Intralipid increased corticosterone levels by nearly 20-fold at 120 min. At 180 min, corticosterone levels were still significantly greater than those in saline controls. Lower doses of Intralipid also significantly elevated both FFA and corticosterone levels, but by 180 min, levels of both were similar to those in controls. The effects of Intralipid on corticosterone secretion could not be attributed to the presence of glycerol in the suspension, since glycerol infusions had no significant effect on steroid levels compared to those in saline controls. In dexamethasone-pretreated rats, there was no significant rise in plasma corticosterone after either of two Intralipid doses, suggesting that the action of Intralipid was at a site within the HPA axis above the adrenal gland. This finding also suggested that the high steroid levels after Intralipid treatment were not due to interference with the corticosterone RIA. This was verified by the finding that there was no increase in plasma immunoreactive corticosterone after Intralipid infusion into adrenalectomized rats. Intralipid also caused an increase in plasma glucose levels that was first significant at 60 min and declined to baseline by 180 min, possibly reflecting increased autonomic activity or peripheral insensitivity to insulin. The results suggest that high circulating FFA levels activate, rather than inhibit, the HPA axis in rats. Since stress activates glucocorticoid production and increases FFA levels due to lipolysis, it is possible that FFA and the HPA axis constitute a previously unrecognized positive feedback loop.(ABSTRACT TRUNCATED AT 400 WORDS)


This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
C. Roberge, A. C. Carpentier, M.-F. Langlois, J.-P. Baillargeon, J.-L. Ardilouze, P. Maheux, and N. Gallo-Payet
Adrenocortical dysregulation as a major player in insulin resistance and onset of obesity
Am J Physiol Endocrinol Metab, December 1, 2007; 293(6): E1465 - E1478.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
F. Lanfranco, L. Gianotti, A. Picu, R. Giordano, G. A. Daga, V. Mondelli, G. Malfi, S. Fassino, E. Ghigo, and E. Arvat
Effects of free fatty acids on ACTH and cortisol secretion in anorexia nervosa.
Eur. J. Endocrinol., May 1, 2006; 154(5): 731 - 738.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
H. A. Shaltout and A. A. Abdel-Rahman
Mechanism of Fatty Acids Induced Suppression of Cardiovascular Reflexes in Rats
J. Pharmacol. Exp. Ther., September 1, 2005; 314(3): 1328 - 1337.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. E. la Fleur, H. Houshyar, M. Roy, and M. F. Dallman
Choice of Lard, But Not Total Lard Calories, Damps Adrenocorticotropin Responses to Restraint
Endocrinology, May 1, 2005; 146(5): 2193 - 2199.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
P. Kok, S. W. Kok, M. M. Buijs, J. J. M. Westenberg, F. Roelfsema, M. Frolich, M. P. M. Stokkel, A. E. Meinders, and H. Pijl
Enhanced circadian ACTH release in obese premenopausal women: reversal by short-term acipimox treatment
Am J Physiol Endocrinol Metab, November 1, 2004; 287(5): E848 - E856.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
F. Lanfranco, R. Giordano, M. Pellegrino, L. Gianotti, J. Ramunni, A. Picu, M. Baldi, E. Ghigo, and E. Arvat
Free Fatty Acids Exert an Inhibitory Effect on Adrenocorticotropin and Cortisol Secretion in Humans
J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1385 - 1390.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Magnan, C. Cruciani, L. Clement, P. Adnot, M. Vincent, M. Kergoat, A. Girard, J.-L. Elghozi, G. Velho, N. Beressi, et al.
Glucose-Induced Insulin Hypersecretion in Lipid-Infused Healthy Subjects Is Associated with a Decrease in Plasma Norepinephrine Concentration and Urinary Excretion
J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4901 - 4907.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. F. Dallman, S. F. Akana, S. Bhatnagar, M. E. Bell, S. Choi, A. Chu, C. Horsley, N. Levin, O. Meijer, L. R. Soriano, et al.
Starvation: Early Signals, Sensors, and Sequelae
Endocrinology, September 1, 1999; 140(9): 4015 - 4023.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
G. Trottier, K. G. Koski, T. Brun, D. J. Toufexis, D. Richard, and C.-D. Walker
Increased Fat Intake during Lactation Modifies Hypothalamic-Pituitary-Adrenal Responsiveness in Developing Rat Pups: A Possible Role for Leptin
Endocrinology, September 1, 1998; 139(9): 3704 - 3711.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
B. M. Tannenbaum, D. N. Brindley, G. S. Tannenbaum, M. F. Dallman, M. D. McArthur, and M. J. Meaney
High-fat feeding alters both basal and stress-induced hypothalamic-pituitary-adrenal activity in the rat
Am J Physiol Endocrinol Metab, December 1, 1997; 273(6): E1168 - E1177.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. J. Grekin, A. P. Vollmer, and R. S. Sider
Pressor Effects of Portal Venous Oleate Infusion : A Proposed Mechanism for Obesity Hypertension
Hypertension, July 1, 1995; 26(1): 193 - 198.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1992 by The Endocrine Society